000739 fundamentals
APELOA PHARMACEUTI revenue breakdown overview
APELOA PHARMACEUTI revenue for the last year amounted to 11.47 B CNY, the most of which — 7.99 B CNY — came from its highest performing source at the moment, API Intermediates, the year earlier bringing 7.74 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought APELOA PHARMACEUTI 6.55 B CNY, and the year before that — 6.00 B CNY.
By source
2016
2017
2018
2019
2020
2021
2022
2023
0.00
3.00 B
6.00 B
9.00 B
12.00 B
API Intermediates
Innovative Drug R&D and Production Services
Preparation
Other Business
Other
Currency: CNY
2016
2017
2018
2019
2020
2021
2022
2023
API Intermediates
5.29 B
5.93 B
6.55 B
7.74 B
7.99 B
Innovative Drug R&D and Production Services
722.08 M
1.06 B
1.39 B
1.58 B
2.00 B
Preparation
1.12 B
760.15 M
867.43 M
1.08 B
1.25 B
Other Business
12.57 M
28.09 M
32.44 M
39.10 M
33.92 M
Other
57.03 M
105.10 M
102.69 M
111.64 M
198.97 M
By country
2016
2017
2018
2019
2020
2021
2022
2023
0.00
3.00 B
6.00 B
9.00 B
12.00 B
China
Foreign
Currency: CNY
2016
2017
2018
2019
2020
2021
2022
2023
China
4.18 B
4.33 B
5.42 B
6.00 B
6.55 B
Foreign
3.03 B
3.55 B
3.52 B
4.55 B
4.92 B